FTC sues main pharmacy reward supervisors around insulin rates The agency brought motion versus Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating tactics “artificially inflated” the listing price of lifestyle-preserving insulin prescription drugs. Elevance lowers guidance on ‘unparalleled’ Medicaid challenges Executives stated the greater ... https://kethek.com/